Ligand Pharmaceuticals Inc (NASDAQ:LGND)

155.53
Delayed Data
As of Feb 22
 -0.81 / -0.52%
Today’s Change
95.08
Today|||52-Week Range
170.30
+13.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues49.0M64.5M71.9M109.0M
 
 
 
 
 
Cost of Goods Sold3.1M6.5M3.2M4.9M
 
 
 
 
 
Depreciation And Amortization2.7M2.7M2.6M11.3M
 
 
 
 
 
 
Operating ExpensesGross Income43.2M55.4M66.1M92.8M
 
 
 
 
 
General Expenses27.3M34.7M37.8M47.8M
 
 
 
 
 
Research And Development9.3M12.1M13.4M21.2M
 
 
 
 
 
Total Operating Expenses33.0M43.8M43.6M64.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income16.0M20.7M28.3M44.9M
 
 
 
 
 
Extraordinary Credit0.00544.0K27.2M300.0K
 
 
 
 
Extraordinary Charge-4.6M-6.8M-5.8M-4.4M
 
 
 
 
 
Pre-Tax Equity Earnings-----5.1M-23.1M
 
 
 
Interest Expense On Debt2.1M4.9M11.8M12.2M
 
 
 
 
 
Other Expenses-63.0K1.7M2.5M2.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income9.2M11.3M35.3M8.0M
 
 
 
 
 
Income Taxes-374.0K-410.0K-192.1M-10.3M
 
 
 
 
 
Minority Interest0.00-1.1M-2.4M0.00
 
 
 
Extraordinary Items2.6M0.000.00731.0K
 
 
 
Net Income8.8M12.0M229.8M-2.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS20.3M20.4M19.8M20.8M
 
 
 
 
 
Shares To Calculate EPS Diluted20.7M21.4M21.2M20.8M
 
 
 
 
 
 
Earnings Per ShareEPS$0.55$0.56$10.83-$0.08
 
 
 
 
 
EPS Diluted$0.43$0.56$10.83-$0.11